Table 3 Parasitological and clinical outcome for patients treated with artesunate-amodiaquine
Outcome | Nagaga ( n = 88) | Mkuzi (n = 88) | Mlimba (n = 88) |
|---|---|---|---|
n (%) | n (%) | n (%) | |
Early treatment failure | 0 (0) | 0 (0) | 0 (0) |
Late clinical failure | 0 (0) | 0 (0) | 0 (0) |
Late parasitological failure | 1 (1.1) | 1 (1.2) | 0 (0) |
Uncorrected adequate clinical and parasitological response | 87 (98.9) | 86 (98.9) | 87 (100) |
PCR-determined reinfection by day 28 | 1 (1.1) | 1 (1.1) | 0 |
Recrudescence | 0 | 0 | 0 |
Withdrawn/lost | 0 | 1 (1.1) | 1 (1.1) |
PCR-corrected adequate clinical and parasitological response | 88 (100) | 87 (100) | 87 (100) |